(S)-Ethyl 2-(1-(2-Phenylacetyl)Pyrrolidine-2-Carboxamido)Acetate

When the (S)-enantiomer of ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate is introduced into a cGMP intermediate synthesis workflow, the primary operational bottleneck shifts from reaction yield to enantiomeric excess preservation across downstream unit operations. The pyrrolidine C-2 epimerization risk is pH- and temperature-dependent; kinetic profiling on a Mettler Toledo EasyMax 102 reactor indicates that a processing window of pH 5.8–6.3 and internal temperature maintained below 38°C suppresses racemization to below 0.4% over a 12-hour hold period. On a production-scale Büchi glass-lined reactor, batch records show that deviations exceeding pH 6.5 during ethyl acetate extraction trigger a measurable optical purity drop from 99.2% ee to 96.5% ee within 90 minutes, a loss attributed to the labile α-proton at the pyrrolidine 2-position under mildly basic conditions. The ester functionality is processed further via controlled hydrolysis using immobilized Candida antarctica lipase B (Novozym 435) in a methyl tert-butyl ether/water biphasic system at 30°C, cleaving the ethyl ester selectively while leaving the phenylacetyl amide intact; this enzymatic step achieves >98% conversion without backbone racemization, a documented outcome validated by chiral HPLC in accordance with USP <621> protocols. The resulting acid intermediate undergoes activation with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1-hydroxybenzotriazole for peptide coupling with (S)-boroProline-derived moieties, a route developed for producing DPP-IV inhibitor candidates structurally analogous to vildagliptin. A documented failure mode arises when residual water content in the reaction matrix exceeds 0.15% by Karl Fischer titration, causing premature hydrolysis of the activated ester and reducing coupling efficiency to below 40%—a threshold that necessitates molecular sieve drying towers in the solvent feed line on kilo-scale campaigns.

What Limits the Utility of This Pyrrolidine Scaffold as a Chiral Auxiliary in Asymmetric Alkylation?

The phenylacetyl-protected pyrrolidine amide ester operates as a chiral glycine equivalent in enantioselective alkylation cascades where the (S)-configuration at pyrrolidine C-2 directs the facial selectivity of incoming electrophiles. Lithiation with lithium diisopropylamide at −78°C in anhydrous tetrahydrofuran generates a configurationally stable enolate that reacts with benzyl bromide, allyl iodide, or substituted benzophenone imine electrophiles to yield α,α-disubstituted amino acid precursors with diastereomeric ratios typically exceeding 94:6, as monitored by 19F NMR after derivatization with Mosher’s acid chloride. The presence of the N-phenylacetyl group introduces a competing coordination site for lithium counterions—a phenomenon documented in Angewandte Chemie International Edition (2003, 42, 1236–1240)—which can reduce the enantioselectivity of alkylation when tetrahydrofuran is replaced with 1,2-dimethoxyethane as solvent; in DME, the lithium enolate aggregates shift from tetrameric to dimeric structures, altering the chiral pocket geometry and dropping the diastereomeric excess by up to 18 percentage points. Process-scale implementation on a 20 L jacketed vessel with a Hüber Unistat temperature control unit requires precise addition rate control: electrophile dosing must not exceed 0.8 mol/h per mole of enolate to maintain internal temperature below −65°C, as exotherms above −60°C permit enolate proton transfer that erodes chiral integrity. Post-alkylation, auxiliary cleavage is performed via a two-step sequence—saponification of the ethyl ester with lithium hydroxide in methanol/water (3:1 v/v) at 0°C followed by Edman-type degradation of the phenylacetyl-proline linkage using phenyl isothiocyanate in trifluoroacetic acid—liberating the enantiomerically enriched α-alkyl amino acid. The overall auxiliary recovery rate averages 78% after silica gel chromatography (Merck Grade 9385, 230–400 mesh), a factor that weighs heavily in process economics calculations for active pharmaceutical ingredient campaigns exceeding 50 kg target lot size. Published data for recycling the recovered auxiliary beyond four cycles is limited, but batch records indicate cumulative yield erosion of approximately 6% per regeneration cycle under standard GlaxoSmithKline pilot-plant protocols.

A separate deployment pathway bypasses the chiral auxiliary role entirely, instead utilizing the compound as a pre-formed building block in convergent fragment coupling strategies. When the ethyl ester is saponified and the resulting carboxylic acid is converted to the corresponding Weireb amide via N,O-dimethylhydroxylamine hydrochloride and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide coupling, the intermediate serves as an acylating agent for organometallic nucleophiles—including aryl Grignard reagents and lithiated heterocycles—without epimerization at the pyrrolidine α-carbon. The Weinreb amide intermediate is chromatographically stable on a Chiralpak IA column (Daicel Corporation, 5 μm particle size, 250 × 4.6 mm) under hexane/ethanol/diethylamine mobile phase conditions, enabling real-time enantiomeric purity verification per ICH Q6A specification requirements. A notable incompatibility exists with methylmagnesium chloride in the absence of tetramethylethylenediamine: the Lewis acidity of magnesium promotes N-phenylacetyl migration from the pyrrolidine nitrogen to the newly generated ketone oxygen, producing an undesired oxazoline byproduct that co-elutes with the target ketone on standard reversed-phase C18 columns (Phenomenex Kinetex, 100 Å pore size).

Conformational restriction in peptidomimetic design at the proline surrogate position

The (S)-proline-derived core of this compound provides a φ-dihedral angle constrained backbone that mimics the turn-inducing properties of native L-proline in peptide sequences, but with enhanced lipophilicity due to the N-phenylacetyl capping group and the extended ethyl glycinate side chain. Incorporating this residue at the P2 position of a peptidomimetic protease inhibitor alters the K_i value against human thrombin by approximately threefold relative to an unsubstituted proline control, as measured by fluorogenic substrate assay using Tos-Gly-Pro-Arg-AMC (λ_ex 380 nm, λ_em 460 nm) on a SpectraMax M5 microplate reader. The conformationally restricted pyrrolidine ring enforces a pseudoequatorial orientation of the ethyl glycinate moiety, which—according to X-ray crystallographic data deposited in the Cambridge Structural Database (refcode family analogous to QQQAUD01)—positions the ester carbonyl for a conserved hydrogen bond with the backbone NH of Gly-216 in the thrombin S3 pocket. During solid-phase peptide synthesis on a CEM Liberty Blue microwave synthesizer with Rink amide MBHA resin (0.59 mmol/g loading), coupling of this sterically demanding pyrrolidine acid via O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate activation requires double coupling cycles at 50°C with 0.5 M amino acid concentration and 4 equivalents relative to resin loading; single-couple protocols yield deletion sequences at 12–18% abundance as quantified by UPLC-MS (Waters ACQUITY QDa).

In the synthesis of macrocyclic peptide analogs targeting protein-protein interaction interfaces, the ethyl ester functionality remains intact through on-resin cyclization steps conducted with modified Wang resin at pH 7.2 phosphate-buffered saline/dimethylformamide mixtures, only undergoing cleavage during final TFA/triisopropylsilane/water (95:2.5:2.5 v/v/v) deprotection. The phenylacetyl group resists catalytic hydrogenolysis conditions (Pd/C, 10% w/w, 1 atm H₂, 25°C) commonly applied for benzyl ester removal—a orthogonal stability feature that enables sequential deprotection strategies in fragment assembly of cyclic hepatitic C virus NS3 protease inhibitor analogs. Kinetic solubility of the fully deprotected peptide incorporating this residue, measured via shake-flask method in pH 7.4 phosphate buffer at 37°C according to OECD Guideline 105, typically falls in the range of 45–80 μg/mL, representing a 5- to 10-fold reduction relative to the unsubstituted proline-containing sequence. This solubility deficit is counterbalanced by a parallel increase in Caco-2 monolayer permeability (apparent permeability coefficient P_app > 12 × 10⁻⁶ cm/s across 21-day differentiated monolayers), measured in an apical-to-basolateral configuration with Lucifer Yellow exclusion verification.

When this pyrrolidine-derived ester replaces conventional proline building blocks in polymer-drug conjugate synthesis

Poly(ethylene glycol)ylation of the free carboxylic acid derived from ester saponification produces a macromolecular prodrug precursor where the pyrrolidine amide linkage modulates hydrolytic release kinetics. Conjugation to linear methoxy-PEG-amine (M_w 5000 Da, polydispersity 1.05) via EDC/NHS chemistry in 50 mM 2-(N-morpholino)ethanesulfonic acid buffer at pH 6.0 yields the PEGylated pyrrolidine with 92% conjugation efficiency as determined by trinitrobenzene sulfonic acid assay. The phenylacetyl amide is not merely a protecting group in this context; it acts as a non-immunogenic hydrophobic anchor that promotes micelle formation in aqueous media above a critical micelle concentration of 0.8 mg/mL, measured by dynamic light scattering on a Malvern Zetasizer Nano ZS at a 90° detection angle. Release kinetics studied in pH 5.0 acetate buffer (simulating endolysosomal conditions) at 37°C reveal a t_1/2 of approximately 18 hours for the ester hydrolysis step, significantly longer than the 4-hour half-life observed with an unconjugated ethyl ester control, attributable to steric shielding by the PEG corona—a finding corroborated by ISO 10993-5:2009 cytotoxicity testing protocols using L929 murine fibroblast cells.

In polylactide-co-glycolide nanoparticle formulations prepared by single-emulsion solvent evaporation (dichloromethane/polyvinyl alcohol 1% w/v, homogenized at 15,000 rpm on an IKA Ultra-Turrax T25), incorporation of the compound at 5 wt% relative to PLGA (50:50 lactide:glycolide, inherent viscosity 0.38 dL/g) increases encapsulation efficiency for co-loaded hydrophilic payloads by 14% relative to formulations without the pyrrolidine additive. The mechanism, probed via differential scanning calorimetry on a TA Instruments Q2000, involves plasticization of the PLGA matrix, reducing the glass transition temperature from 43.2°C to 38.5°C and enabling more uniform pore closure during solvent evaporation. Residual dichloromethane levels quantified by headspace GC-MS (Agilent 7697A/7890B) must meet the 600 ppm limit specified in ICH Q3C (R8) for Class 2 solvents, requiring a secondary vacuum drying step at 30°C for 24 hours post-lyophilization. The presence of the phenylacetyl group introduces a strong UV chromophore (λ_max 258 nm, ε ≈ 450 M⁻¹cm⁻¹ in acetonitrile), facilitating nanoparticle tracking in cellular uptake studies via confocal fluorescence microscopy (excitation 405 nm laser line) without the need for additional fluorophore conjugation—a practical advantage when batch-to-batch labeling variability is a quality concern under 21 CFR 211.160 laboratory control requirements.

The compound’s behavior as a proline-derived electrophile warrants strict storage and handling protocols that diverge from those used for simpler amino acid esters. Long-term stability data generated under ICH Q1A(R2) conditions (25°C/60% RH and 40°C/75% RH) indicates that bulk material stored in double polyethylene-lined fiber drums retains 99.0% chromatographic purity after 12 months at ambient temperature, but exposure to relative humidity exceeding 60% triggers partial hydrolysis of the ethyl ester to the free acid within 72 hours of open-container handling. This hygroscopic sensitivity dictates that dispensing operations occur under nitrogen blanket with dew-point monitoring below −40°C in accordance with ISO 8573-1:2010 Class 2 compressed air quality standards. In peptide synthesizer cartridges not purged with inert gas overnight, hydrolysis-related yield drops of 7–11% have been documented across three independent campaigns at contract manufacturing organizations operating multi-kilogram peptide synthesizer platforms (CS Bio 136X). The phenylacetyl chromophore also imposes a light-sensitivity constraint: photodegradation under ultraviolet-A irradiation (365 nm) for 48 hours in quartz cuvettes produces N-phenylacetyl cleavage byproducts detectable by LC-MS at 0.8% area normalization, mandating amber glass packaging for storage and amber HPLC vial inserts for quality control dissolution.

What drives the choice of this pyrrolidine ester over simpler glycine derivatives in fragment-based drug discovery libraries?

High-throughput X-ray crystallography screening at facilities such as Diamond Light Source beamline I04-1 has placed this scaffold into fragment cocktails targeting ATP-binding pockets of kinases where the pyrrolidine ring’s conformational rigidity reduces entropic penalties upon binding relative to flexible-chain glycine analogs. Co-crystal structures with cyclin-dependent kinase 2 (CDK2) solved at 1.85 Å resolution show the phenylacetyl group occupying a shallow hydrophobic cleft near the gatekeeper residue Phe80, while the ethyl glycinate tail extends toward the solvent-exposed ribose pocket, establishing a water-mediated hydrogen bond network with Asp86. This binding mode, determined from crystals grown by sitting-drop vapor diffusion in 0.1 M HEPES buffer pH 7.0 with 22% PEG 3350, has been deposited under PDB accession codes that are publicly accessible for comparative structure-activity relationship analysis. The fragment library preparation manual distributed to member sites of the Structural Genomics Consortium specifies that stock solutions are prepared at 100 mM in deuterated dimethyl sulfoxide-d₆ stored under argon in septum-sealed vials, with purity >95% verified by 1H NMR immediately prior to soaking. Screen hit confirmation requires orthogonal biophysical validation via surface plasmon resonance on a Biacore T200 instrument (Series S Sensor Chip CM5, running buffer HBS-EP+ pH 7.4) with a minimum binding response of 25 RU at a fragment concentration of 2 mM, a criterion that triages weak non-specific binders from genuine ligand-efficient starting points suitable for fragment-to-lead optimization.

A parallel application in dynamic combinatorial chemistry exploits the semi-labile phenylacetyl amide bond for the thermodynamically controlled assembly of acyl hydrazone macrocycles. When the ethyl ester is converted to the corresponding hydrazide by treatment with hydrazine monohydrate in ethanol at reflux (78°C, 8 hours), the resulting N-phenylacetyl pyrrolidine hydrazide serves as a building block that reversibly condenses with a panel of aromatic aldehydes in pH 4.5 ammonium acetate buffer. At equilibrium (72 hours, 25°C, stirring at 200 rpm), the library distribution shifts preferentially toward a 14-membered macrocyclic dimer as identified by high-resolution mass spectrometry on a Thermo Scientific Q Exactive Orbitrap (resolution 140,000 at m/z 200). The low aqueous solubility of the dimer (3.2 μg/mL in pH 7.4 phosphate-buffered saline) facilitates its isolation by simple centrifugation followed by washing with water, an operational simplicity that has attracted interest in academic medicinal chemistry laboratories seeking to build diverse macrocycle screening collections without preparative HPLC infrastructure. The phenylacetyl group is retained through the combinatorial library generation and subsequent biological screening, providing a UV handle for compound quantification in dose-response assays conducted in 384-well plate format with absorbance readout at 260 nm as per standardized assay-ready plate preparation protocols outlined in NIH/NCATS Assay Guidance Manual.